Skip to content
Clinical Trials – home

Protein S: A Crucial Component in Blood Clotting and Its Role in Medical Treatments

3 / 4
trials open to patients / all trials
13+
Countries

In short

Recent clinical trials are investigating the use of Protein S, a crucial component in blood coagulation, as part of combination therapies for managing various bleeding disorders and anticoagulation reversal. These studies aim to evaluate the safety and efficacy of treatments containing Protein S along with other coagulation factors in different clinical scenarios, from urgent surgery to major bleeding events.

What is Protein S?

Protein S is a naturally occurring protein in the human body that plays a crucial role in the blood clotting process. It is one of several important components found in blood plasma that help regulate coagulation, which is the process of blood clot formation. Protein S is also known by other names, including vitamin K-dependent protein S and blood-coagulation factor XIV.

Function of Protein S

The primary function of Protein S is to act as a natural anticoagulant, which means it helps prevent excessive blood clotting. It works in conjunction with another protein called Protein C to regulate the coagulation cascade, which is a series of chemical reactions that lead to the formation of blood clots.

Specifically, Protein S acts as a cofactor for activated Protein C. Together, they inactivate certain clotting factors (Factor Va and Factor VIIIa), which helps to slow down the clotting process and prevent the formation of unnecessary or harmful blood clots.

Medical Uses

Protein S, along with other coagulation factors, is used in medical treatments primarily for managing bleeding disorders and reversing the effects of certain anticoagulant medications. Some of the medical uses include:

  • Reversing anticoagulation: Protein S is a component of prothrombin complex concentrates (PCCs) used to reverse the effects of anticoagulant drugs, particularly in emergency situations.
  • Managing bleeding in patients with factor deficiencies: PCCs containing Protein S can be used to treat or prevent bleeding in patients with deficiencies of certain coagulation factors.
  • Emergency surgery: In patients requiring urgent surgery who are on anticoagulant therapy, products containing Protein S may be used to quickly reverse the anticoagulant effects and reduce the risk of excessive bleeding during the procedure.

Clinical Trials and Research

Several clinical trials are investigating the use of products containing Protein S for various medical conditions:

  • Reversal of anticoagulation in emergency situations: A Phase 3 trial is studying the effectiveness of a prothrombin complex concentrate (which includes Protein S) in reversing the effects of factor Xa inhibitors (a type of anticoagulant) in patients requiring urgent surgery or experiencing major bleeding.
  • Thrombosis prevention in orthopedic surgery: Another study is investigating different thrombosis prevention strategies, including the use of products containing coagulation factors, in patients undergoing total hip or knee replacement surgery.
  • Management of major bleeding: A clinical trial is assessing the effectiveness of a four-factor prothrombin complex concentrate (which includes Protein S) in managing acute major bleeding in patients taking direct oral anticoagulants.

Safety and Side Effects

While products containing Protein S are generally considered safe when used as directed, there are potential risks and side effects to be aware of:

  • Thrombotic events: In rare cases, the use of prothrombin complex concentrates may increase the risk of blood clot formation.
  • Allergic reactions: Some patients may experience allergic reactions to the components of these products.
  • Transmission of infectious agents: As these products are derived from human plasma, there is a theoretical risk of transmitting infectious agents, although modern manufacturing processes have greatly reduced this risk.

It's important to note that these products should only be used under the supervision of a healthcare professional, who will weigh the potential benefits against the risks for each individual patient.

Conclusion

Protein S plays a vital role in the body's natural blood clotting processes. Its inclusion in medical products, particularly prothrombin complex concentrates, has made it an important tool in managing various bleeding disorders and reversing the effects of anticoagulant medications. Ongoing research continues to explore new applications and refine existing treatments involving Protein S, with the goal of improving patient outcomes in emergency situations and various medical procedures.

Questions people often ask

Conditions where Protein S is being studied

Each condition opens its own overview and trial list

Trials with Protein S

Recruiting trials first

See all 4 →
Quick filters
  • Participants:Adults
  • Participants:Adults · Healthy volunteers
  • Participants:Adults
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.